Literature DB >> 15024626

Risk factors for mortality in patients with anaerobic bacteremia.

J R Wilson1, A P Limaye.   

Abstract

Risk factors for mortality in anaerobic bacteremia have been incompletely defined. The aims of the present study were to determine clinical significance by pathogen for a broad range of obligate anaerobic organisms isolated from blood, and to define the factors independently associated with mortality among those with clinically significant bacteremia. All patients who had anaerobic bacteria isolated from blood over a 19-month period (from 1 September 1998 to 1 April 2000) at two urban teaching hospitals were included in this study. Each case was analyzed for clinical significance by means of a retrospective medical record review using predetermined definitions. Information was collected on a broad range of clinical and microbiological factors, which were evaluated for their association with mortality using a Cox proportional hazards model. Among 166 patients with obligate anaerobic bacteria isolated from blood, 73 (44%) were deemed to have clinically significant bacteremia. Clinical significance ranged from 0% (0/53) for Propionibacterium spp. to 96% (43/45) for Bacteroides spp. The crude mortality rate in patients with clinically significant anaerobic bacteremia was 25% (18/73). Mortality was significantly associated with age, polymicrobial infection, and underlying heart, kidney or liver disease in univariate analysis. Only the presence of liver disease (relative risk, 5.3; 95% confidence interval, 1.7-16.0; P=0.003) and patient age (relative risk, 1.06/y; 95% confidence interval, 1.0-1.1; P=0.005) remained significant in multivariate analysis. Among patients with anaerobic bacteremia, clinical significance varies markedly by pathogen and mortality is independently associated with age and underlying liver disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024626     DOI: 10.1007/s10096-004-1111-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  43 in total

1.  Bacteremia due to Bacteroides. Review of 11 cases.

Authors:  M C MCHENRY; W E WELLMAN; W J MARTIN
Journal:  Arch Intern Med       Date:  1961-04

2.  Bacteroides bacteremia.

Authors:  P F Lawrence; G W Tietjen; S Gingrich; T C King
Journal:  Ann Surg       Date:  1977-11       Impact factor: 12.969

3.  Clostridial bacteremia in the community hospital.

Authors:  R I Haddy; D D Nadkarni; B L Mann; D R Little; T D Domers; R D Clover; M J Silvers
Journal:  Scand J Infect Dis       Date:  2000

4.  Anaerobic bacterial bacteremia: 12-year experience in two military hospitals.

Authors:  I Brook
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

5.  Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms.

Authors:  E Bouza; M Reig; M Garcia de la Torre; M Rodríguez-Créixems; J Romero; E Cercenado; F Baquero
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

6.  Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

Authors:  J Gómez; V Baños; J Ruiz; F Herrero; M Pérez; L Pretel; M Canteras; M Valdés
Journal:  Clin Investig       Date:  1993-08

7.  Clinical assessment of anaerobic isolates from blood cultures.

Authors:  S E Sharp; J C McLaughlin; J M Goodman; J Moore; S M Spanos; D W Keller; R J Poppiti
Journal:  Diagn Microbiol Infect Dis       Date:  1993-07       Impact factor: 2.803

8.  Bacteremia due to Fusobacterium species.

Authors:  S Henry; A DeMaria; W R McCabe
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

9.  Bacteroides bacteremia. Analysis of 142 episodes from one metropolitan area.

Authors:  C S Bryan; K L Reynolds; B Kirkhart; J J Brown
Journal:  Arch Surg       Date:  1984-08

10.  Clinical significance and outcome of anaerobic bacteremia.

Authors:  J H Salonen; E Eerola; O Meurman
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more
  18 in total

Review 1.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

2.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

Review 3.  Current and past strategies for bacterial culture in clinical microbiology.

Authors:  Jean-Christophe Lagier; Sophie Edouard; Isabelle Pagnier; Oleg Mediannikov; Michel Drancourt; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

4.  Risk Factors for Resistance to β-Lactam/β-Lactamase Inhibitors and Ertapenem in Bacteroides Bacteremia.

Authors:  Janessa M Smith; Edina Avdic; Pranita D Tamma; Long Zhang; Karen C Carroll; Sara E Cosgrove
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

5.  Bacteriology of peritonsillar abscess in patients over 40 years--a neglected age group.

Authors:  Haim Gavriel; Yitzhak Golan; Tsilia Lazarovitch; Ephraim Eviatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-08       Impact factor: 2.503

6.  Clinical significance of Propionibacterium acnes recovered from blood cultures: analysis of 524 episodes.

Authors:  Hyun Jung Park; Shin Na; Seong Yeon Park; Song Mi Moon; Oh-Hyun Cho; Ki-Ho Park; Yong Pil Chong; Sung-Han Kim; Sang-Oh Lee; Yang Soo Kim; Jun Hee Woo; Mi-Na Kim; Sang-Ho Choi
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

7.  Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment.

Authors:  A Deloris Alexander; Roger P Orcutt; Janell C Henry; Joseph Baker; Anika C Bissahoyo; David W Threadgill
Journal:  Mamm Genome       Date:  2006-11-07       Impact factor: 2.957

8.  Clinical significance of anaerobic infections.

Authors:  Dong Gun Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 2.884

9.  Oxygen tolerance in anaerobic pathogenic bacteria.

Authors:  Ondřej Holý; Dittmar Chmelař
Journal:  Folia Microbiol (Praha)       Date:  2012-05-10       Impact factor: 2.099

10.  Expression of Bacteroides fragilis hemolysins in vivo and role of HlyBA in an intra-abdominal infection model.

Authors:  Leandro A Lobo; Audrey L Jenkins; C Jeffrey Smith; Edson R Rocha
Journal:  Microbiologyopen       Date:  2013-02-26       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.